Skip to content

Bladder Papillary Urothelial Carcinoma C1518882

Published: July 22, 2026Updated: August 27, 2026

A type of bladder cancer that forms papillary (finger-like) growths in the bladder lining. It primarily affects older adults and is often treated with surgery, sometimes followed by chemotherapy or immunotherapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Gross hematuria

(oncologic)

Urinary urgency

(oncologic)

Dysuria

(oncologic)

Suprapubic pain

(oncologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Transurethral resection of bladder tumor

TURBT is the primary diagnostic and therapeutic procedure for non-muscle-invasive papillary urothelial carcinoma. Complete resection of all visible tumor tissue is essential for accurate staging.

surgical
3

Intravesical BCG immunotherapy

Bacillus Calmette-Guerin immunotherapy is instilled directly into the bladder to reduce recurrence and progression in high-risk non-muscle-invasive papillary carcinoma. Treatment involves induction and maintenance phases.

medication

Additional treatment options

Photodynamic therapy or laser ablation

Laser ablation or photodynamic therapy offers bladder-preserving alternatives for selected superficial papillary tumors, particularly in patients who cannot undergo BCG therapy.

procedure

Routine cystoscopic surveillance

Regular cystoscopic examinations with urine cytology detect early tumor recurrence in patients with papillary urothelial carcinoma. Surveillance schedules are tailored to risk stratification.

monitoring

Dietary modification

Increased fluid intake and reduced consumption of processed foods and animal fats may help reduce bladder cancer recurrence risk. Antioxidant-rich foods are encouraged.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Bladder Papillary Urothelial Carcinoma C1518882?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Babjuk M, Burger M, Compérat EM, et al. European Association of Urology Guidelines on Non-Muscle-Invasive Bladder Cancer. Eur Urol. 2022.

guideline2022
2

Soria F, D'Andrea D, Gust K, Shariat SF. Papillary Urothelial Neoplasm: Pathological Features and Clinical Outcomes. Urol Oncol. 2021.

review2021
3

Kamat AM, Hahn NM, Efstathiou JA, et al. A Prospective Randomized Trial of Adjuvant Intravesical Therapy for High-Risk Papillary Urothelial Carcinoma. J Clin Oncol. 2020.

clinical_trial2020
4

Meeks JJ, Brausi MA, Gakis G, et al. Recurrence and Progression of Low-Grade Papillary Bladder Cancer: A Systematic Review and Meta-Analysis. Eur Urol Oncol. 2019.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Bladder Papillary Urothelial Carcinoma C1518882. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy